36
landing page
Future of Health Summit 2017
report
Comment Letter to the OCC: Licensing Manual Draft Supplement on Evaluating Charter Applications from FinTech Companies
The Milken Institute Center for Financial Markets provided a response to the Office
of the Comptroller of the Currency’s (OCC) Licensing Manual Draft Suppl
+ Read More
report
How Resilient Are Sub-Saharan Countries to External Shocks?
Growth in most emerging economies did not take as hard a hit as expected during the great recession
of 2008.
+ Read More
report
The Asset Management Industry, Systemic Risk, and Macroprudential Policy
In the aftermath of the 2007-2008 financial crisis, new legislation and regulations have pressured
banks and insurance companies to reduce their size, leverage, and riskier lines of business in order to avoid another too-big-to-fail debacle.
+ Read More
report
Concept to Commercialization: The Best Universities for Technology Transfer
Innovative activities – and their commercial applications – are driving long-term economic growth i
n America.
+ Read More
report
New Models for Financing Infrastructure in Asia
With nearly 60 percent of the global population and still growing, it’s no surprise that Asia’s gro
wth continues to surpass that of other regions.
+ Read More
video
Panel: Reducing Drag: New Approaches to IP Negotiation and Technology Licensing
David Clifford, Robert Cook-Deegan, Steven M. Ferguson, Justin McCarthy, Lita Nelsen, Josh Sommer
video
Panel - Mental Health: Research and Development at a Crossroads
Kathi E. Hanna, Thomas R. Insel, Jay Lombard, Jeffrey Nye, Robert Ring, Paul Weiss
video
Plenary: Five People Changing the Face of Bioscience
Laura Deming, Geoffrey Ling, Jessica Richman, Josh Sommer, Halle Tecco, Adrien Treuille
video
Plenary: Investing in Bioscience: Linking Financial, Human, and Social Returns
Christopher Egerton-Warburton, Robert Hugin, Rajiv Kaul, Michael Milken, Richard Pops
video
Plenary: Big Data Needs Big Ideas
Thomas Frieden, Jeff Hammerbacher, Lesa Mitchell, Gary J. Nabel, Andy Palmer, Roni Zeiger
video
Panel: FDA: Recalibrating the Benefit-Risk Equation
Robert Conley, Geoff Duyk, Patrick Frey, Hugh Hempel, Howard McLeod, Kate Rawson